Opinion|Videos|November 20, 2026

How to Diagnose Barth Syndrome in 2026

Dr. Vernon describes the evolution of genetic diagnosis -- from single-gene sequencing to whole exome/genome sequencing now achievable in 8 days for $3,000 -- compressing median time-to-diagnosis from years to months.

Dr. Vernon describes the evolution of genetic diagnosis -- from single-gene sequencing to whole exome/genome sequencing now achievable in 8 days for $3,000 -- compressing median time-to-diagnosis from years to months. She covers the limitations of disease-specific panels (TAZ may not appear), the diagnostic role of cardiolipin profiling (confirms disease and resolves VUS), and ACMG variant classification standards. Dr. Husain asks about cascade screening; Dr. Vernon reports ~20% VUS rate in her cohort, all resolved through clinical correlation and/or cardiolipin testing. The segment closes on the importance of recording all clinical features on the test order form.


Related to this article